Dose-Response Effects of Insulin Glargine in Type 2 Diabetes

OBJECTIVE: To determine the pharmacokinetic and pharmacodynamic dose-response effects of insulin glargine administered subcutaneously in individuals with type 2 diabetes. RESEARCH DESIGN AND METHODS: Twenty obese type 2 diabetic individuals (10 male and 10 female, aged 50 ± 3 years, with BMI 36 ± 2...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Zhihui, Hedrington, Maka S., Gogitidze Joy, Nino, Briscoe, Vanessa J., Richardson, M. Antoinette, Younk, Lisa, Nicholson, Wendell, Tate, Donna B., Davis, Stephen N.
Formato: Texto
Lenguaje:English
Publicado: American Diabetes Association 2010
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2890358/
https://www.ncbi.nlm.nih.gov/pubmed/20357371
http://dx.doi.org/10.2337/dc09-2011

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2890358/
https://www.ncbi.nlm.nih.gov/pubmed/20357371
http://dx.doi.org/10.2337/dc09-2011

Ejemplares similares